(Q39111439)

9 September 2017

title

Are men testing? Sex differentials in HIV testing in Mpumalanga Province, South Africa (English)

1 reference

9 September 2017

0 references

R. C. Snow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20824559

8 July 2024

M. Madalane

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20824559

8 July 2024

M. Poulsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20824559

8 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20824559

8 July 2024

publication date

1 September 2010

1 reference

full work available at URL

9 September 2017

https://www.tandfonline.com/doi/pdf/10.1080/09540120903193641

1 reference

https://api.crossref.org/works/10.1080/09540120903193641

8 July 2024

1 reference

9 September 2017

volume

22

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

1060-1065

1 reference

HIV testing and the role of individual- and structural-level barriers and facilitators.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

HIV prevention for a threatened continent: implementing positive prevention in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Positive and negative life events after counselling and testing: the Voluntary HIV-1 Counselling and Testing Efficacy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

A public health dilemma: a testing question

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Relative risk of HIV infection among young men and women in a South African township

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Women's barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

HIV testing in national population-based surveys: experience from the Demographic and Health Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Determinants of HIV counselling and testing participation in a prevention of mother-to-child transmission programme in rural Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Two and a half years of routine HIV testing in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903193641

Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1080/09540120903193641

High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

8 July 2024

10

1 reference

https://api.crossref.org/works/10.1080/09540120903193641

8 July 2024

Identifiers

1 reference

9 September 2017

1 reference